CSL Ltd Annual Report 2019

4. Executive Key Management Personnel Outcomes in 2019 4.1 CSL Performance The following performance outcomes were achieved resulting in an average overall STI payment outcome of 96% of target level opportunity across the Executive KMP (see Table 4). The minimum STI earned as a percentage of target level opportunity was 86% and the maximumwas 123% – the latter was 96% of the maximum STI outcome that could be achieved. Additional quantitative objectives, which were also integral to the achievement of individual performance, were considered by the Board when assessing Executive KMP performance, remain confidential for commercial reasons. Table 3: CSL Achievements in 2019 CSL Group Financial Component NPAT CFO Outcome ● ● Reported NPAT above target at US$1,918.7m Reported CFO below target at US$1,644.4m Individual Strategy Component Growth Efficiency Influenza Innovation People and Culture Outcome ● ● ● ● ● • Reported revenue of US$8,538.6m • Acquisition of the South Carolina Haemonetics manufacturing facility and operating assets • Strategic partnership with Chinese pharmaceutical company Sinopharm to enhance the accessibility of our products in China • 30 Plasma centres opened taking our total to 237 globally • Successful implementation in Europe and the Americas of the new Enterprise Resource Planning (ERP) system • Launch of the new global tender management application • New research facility (Bio21) opened in Melbourne • Major capital projects at all manufacturing sites progressing to support future demand • FCC 3.0 process approved for Holly Springs, influenza cell culture facility, delivering future capacity expansion • Seqirus reported revenue of US$1,195.7m • Seqirus reported CFO of US$208.1m • Launch of the Therapeutic Area framework • Subcutaneous immunoglobulin, Hizentra® (20% liquid SCIG), approved for CIDP in Australia • Hizentra® and Privigen® approved for CIDP in Japan • Five new products into human clinical trials • Patient recruitment for CSL112 trial (cardiovascular disease) progressing well and ahead of target • CSL named in the Top 100 Global Diversity and Inclusion Index (Thomson Reuters) • CSL named in the Top 50 companies for Diversity in the US (Forbes) • Continued employee engagement scores above the global IBM norm • Safety targets partially met ● Target Exceeded ● Target Met ● Target Partially Met ● Target Not Met CSL Limited Annual Report 2019 67